Insider trades

Farrell Simon, Chief Officer of Trevi Therapeutics TRVI, has filed 0 purchases and 2 sales on the open market. The latest trade was on 02/19.

Farrell Simon

Chief Commercial Officer
First filing
23/02/16
Trades
18 trades
Buys / sales
0 / 2
12-month net buying
No record
Last trade
02/19

Trading activity

Transactions

Trade type
TRVI
Open-market sale10b5-1 plan25/03/1025/03/1281,313 sh2 trades$6.75avg.$549,063.49−51.4%